G protein-coupled receptor
α1D-adrenoceptor
Alpha-1D adrenergic receptor
- GeneADRA1D
- FamilyAdrenoceptors
- Groupα1-adrenoceptors
In the mid 1980s the concept of α1 subtypes was first suggested, on the basis of different affinities for the agonist oxymetazoline and the antagonists WB4101 and phentolamine. Studies with radioligand binding and functional experiments then identified three native prazosin-high-affinity subtypes, α1A, α1B and α1D, which correspond to the three subtypes α1a, α1b and α1d characterized by molecular cloning, according to a review of 1999. Many α1 antagonists prescribed for benign prostatic hyperplasia do not distinguish between α1A, α1B and α1D in vitro, and yet they are well tolerated, with a low incidence of cardiovascular effects.1
Sources (1)
- Langer 1999Langer SZ (1999) History and nomenclature of alpha1-adrenoceptors Eur Urol
Binding affinity (Kᵢ)
2 substances, 2 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
2 measurements
5-MeO-DMT439 nMHalberstadt et al. 2012
- Assay
- cloned human receptor; [125I]HEAT competition binding (NIMH PDSP)
- Shown value from
- Halberstadt et al. 2012, Table 1
- Error
- ± 52 SEM
AL-LAD1300 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.